Decreased expression of heme oxygenase is associated with depressive symptoms and may contribute to depressive and hypertensive comorbidity

References

• Burgic-Radmanovic M, Trkulja D, Banjac V, Burgic S, Dragojevic S, Nikolic A. P01–17 - Hypertension in comorbidity with depression. Eur Psychiatry 2010;25:237. doi: 10.1016/S0924-9338(10)70236-4
   Google Scholar
• Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens 2012;30(5):842–51. doi: 10.1097/HJH.0b013e32835080b7
   PubMed Web of Science ®Google Scholar
• Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the national health and nutrition examination survey I epidemiologic follow-up study. Arch Fam Med 1997;6(1):43–9. doi: 10.1001/archfami.6.1.43
   PubMedGoogle Scholar
• Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013;11(1):129. doi: 10.1186/1741-7015-11-129
   PubMed Web of Science ®Google Scholar
• Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care 2008;31(Suppl. 2):S185–9. doi: 10.2337/dc08-s246
   PubMedGoogle Scholar
• Herrera MD, Mingorance C, Rodríguez-Rodríguez R, Alvarez de Sotomayor M. Endothelial dysfunction and aging: an update. Ageing Res Rev 2010;9(2):142–52. doi: 10.1016/j.arr.2009.07.002
   PubMed Web of Science ®Google Scholar
• Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013;18(5):595–606. doi: 10.1038/mp.2012.33
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011;35(3):804–17. doi: 10.1016/j.neubiorev.2010.10.001
   PubMed Web of Science ®Google Scholar
• Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012;36(2):764–85. doi: 10.1016/j.neubiorev.2011.12.005
   PubMed Web of Science ®Google Scholar
• Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinol Lett 2011a;32(1):7–24.
   PubMed Web of Science ®Google Scholar
• Maes M. The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008;29(3):287–91.
   PubMed Web of Science ®Google Scholar
• Palta P, Samuel L, Miller ER, Szanton SL. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 2014;76(1):12–19. doi: 10.1097/PSY.0000000000000009
   PubMed Web of Science ®Google Scholar
• Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999;32(8):595–603. doi: 10.1016/S0009-9120(99)00075-2
   PubMed Web of Science ®Google Scholar
• Stec DE, Ishikawa K, Sacerdoti D, Abraham NG. The emerging role of heme oxygenase and its metabolites in the regulation of cardiovascular function. Int J Hypertens 2012;2012:593530. doi: 10.1155/2012/593530
   PubMedGoogle Scholar
• Smarr KL, Keefer AL. Measures of depression and depressive symptoms: beck depression inventory-II (BDI-II), center for epidemiologic studies depression scale (CES-D), geriatric depression scale (GDS), hospital anxiety and depression scale (HADS), and patient health questionnaire. Arthritis Care Res 2011;63(S11):S454–66. doi: 10.1002/acr.20556
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70(1):158–69.
   PubMed Web of Science ®Google Scholar
• Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114–21. doi: 10.1016/S0076-6879(84)05015-1
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247(10):3170–5.
   PubMed Web of Science ®Google Scholar
• Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007;38(2):247–52. doi: 10.1016/j.arcmed.2006.10.005
   PubMed Web of Science ®Google Scholar
• Stefanescu C, Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord 2012;143(1–3):34–8. doi: 10.1016/j.jad.2012.05.022
   PubMed Web of Science ®Google Scholar
• Bilici M, Efe H, Köroğlu MA, Uydu HA, Bekaroğlu M, Değer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001;64(1):43–51. doi: 10.1016/S0165-0327(00)00199-3
   PubMed Web of Science ®Google Scholar
• Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007;22(2):67–73. doi: 10.1002/hup.829
   PubMed Web of Science ®Google Scholar
• Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep Commun Free Radic Res 2003a;8(6):365–70. doi: 10.1179/135100003225003393
   PubMed Web of Science ®Google Scholar
• Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Neuro Endocrinol Lett 2011b;32(2):133–40.
   PubMed Web of Science ®Google Scholar
• Behr GA, Moreira JCF, Frey BN. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev 2012;2012:1–13. doi: 10.1155/2012/609421
   Web of Science ®Google Scholar
• Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacic M, Matic D, et al. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 2006;20(2):149–55. doi: 10.1038/sj.jhh.1001945
   PubMed Web of Science ®Google Scholar
• Pedro-Botet J, Covas MI, Martín S, Rubiés-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 2000;14(6):343–5. doi: 10.1038/sj.jhh.1001034
   PubMed Web of Science ®Google Scholar
• Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998;16(9):1267–71. doi: 10.1097/00004872-199816090-00007
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska K, Kornatowski T, Bartosz G, Pawluk H, Czuczejko J, Kedziora J, et al. Production of nitric oxide, lipid peroxidation and oxidase activity of ceruloplasmin in blood of elderly patients with primary hypertension. Effects of perindopril treatment. Aging Clin Exp Res 2006;18(1):1–6. doi: 10.1007/BF03324634
   PubMed Web of Science ®Google Scholar
• Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(5):1284–90. doi: 10.1016/j.pnpbp.2011.03.021
   PubMed Web of Science ®Google Scholar
• Ke B, Shen X-D, Zhai Y, Gao F, Busuttil RW, Volk H-D, et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 2002;13(15):1845–57. doi: 10.1089/104303402760372945
   PubMed Web of Science ®Google Scholar
• Tsuchihashi S, Livhits M, Zhai Y, Busuttil RW, Araujo JA, Kupiec-Weglinski JW. Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection. J Immunol 2006;177(7):4749–57. doi: 10.4049/jimmunol.177.7.4749
   PubMed Web of Science ®Google Scholar
• Pae H-O, Kim E-C, Chung H-T. Heme oxygenase and carbon monoxide: medicine chemistry and biological effects guest editor: Yuji Naito integrative survival response evoked by heme oxygenase-1 and heme metabolites. J Clin Biochem Nutr 2008;42(3):197–203. doi: 10.3164/jcbn.2008029
   PubMed Web of Science ®Google Scholar
• Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 2009;110(2):469–85. doi: 10.1111/j.1471-4159.2009.06160.x
   PubMed Web of Science ®Google Scholar
• Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 2010;38(17):5718–34. doi: 10.1093/nar/gkq212
   PubMed Web of Science ®Google Scholar
• Attucks OC, Jasmer KJ, Hannink M, Kassis J, Zhong Z, Gupta S, et al. Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of bach1 activity. PLoS ONE 2014;9(7):e101044. doi: 10.1371/journal.pone.0101044
   Google Scholar
• Rybka J, Kędziora-Kornatowska K, Banaś-Leżańska P, Majsterek I, Carvalho LA, Cattaneo A, et al. Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med 2013;63:187–94. doi: 10.1016/j.freeradbiomed.2013.05.019
   PubMed Web of Science ®Google Scholar
• Belcher JD, Nath KA, Vercellotti GM. Vasculotoxic and proinflammatory effects of plasma heme: cell signaling and cytoprotective responses. ISRN Oxidative Med 2013;2013:1–9. doi: 10.1155/2013/831596
   Google Scholar
• Cozzi A, Levi S, Corsi B, Santambrogio P, Campanella A, Gerardi G, et al. Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. FEBS Lett 2003;537(1–3):187–92. doi: 10.1016/S0014-5793(03)00114-5
   PubMed Web of Science ®Google Scholar
• Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002;8(3):240–6. doi: 10.1038/nm0302-240
   PubMed Web of Science ®Google Scholar
• Marcantoni E, Di Francesco L, Dovizio M, Bruno A, Patrignani P. Novel insights into the vasoprotective role of heme oxygenase-1. Int J Hypertens 2012;2012:1–12. doi: 10.1155/2012/127910
   Google Scholar
• Botros FT, Schwartzman ML, Stier CT, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005;68(6):2745–55. doi: 10.1111/j.1523-1755.2005.00745.x
   PubMed Web of Science ®Google Scholar
• Alba G, El Bekay R, Chacón P, Reyes ME, Ramos E, Oliván J, et al. Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils. J Leukoc Biol 2008;84(2):397–405. doi: 10.1189/jlb.0108035
   PubMed Web of Science ®Google Scholar
• Mancuso C, Santangelo R, Calabrese V. The heme oxygenase/biliverdin reductase system: a potential drug target in Alzheimer's disease. J Biol Regul Homeost Agents 2013;27(2 Suppl):75–87.
   PubMed Web of Science ®Google Scholar
• Lin H-Y, Yeh W-L, Huang B-R, Lin C, Lai C-H, Lin H, et al. Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons. PLoS ONE 2012;7(11):e50138. doi: 10.1371/journal.pone.0050138
   PubMed Web of Science ®Google Scholar
• Eom HW, Park SY, Kim YH, Seong SJ, Jin ML, Ryu EY, et al. Bambusae caulis in Taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1- and Nrf-2-mediated pathways. Int J Mol Med 2012;30(6):1512–20.
   PubMed Web of Science ®Google Scholar
• Tronel C, Rochefort GY, Arlicot N, Bodard S, Chalon S, Antier D. Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model. Oxid Med Cell Longev 2013;2013:1–10. doi: 10.1155/2013/264935
   Web of Science ®Google Scholar
• Zhao J, Moore AN, Redell JB, Dash PK. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci Off J Soc Neurosci 2007;27(38):10240–8. doi: 10.1523/JNEUROSCI.1683-07.2007
   PubMed Web of Science ®Google Scholar